IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,673 | -20.6% | 1,026,965 | +22.9% | 0.01% | -12.5% |
Q2 2023 | $5,882 | +42.1% | 835,494 | +23.4% | 0.01% | +33.3% |
Q1 2023 | $4,138 | +9.5% | 677,309 | +14.5% | 0.01% | +20.0% |
Q4 2022 | $3,780 | -99.9% | 591,523 | +4.8% | 0.01% | -37.5% |
Q3 2022 | $5,408,000 | -11.7% | 564,495 | +1.7% | 0.01% | 0.0% |
Q2 2022 | $6,125,000 | -29.5% | 554,825 | +6.4% | 0.01% | -11.1% |
Q1 2022 | $8,686,000 | -12.8% | 521,689 | 0.0% | 0.01% | -10.0% |
Q4 2021 | $9,959,000 | -36.1% | 521,689 | -17.4% | 0.01% | -41.2% |
Q3 2021 | $15,574,000 | -8.4% | 631,553 | -3.3% | 0.02% | -5.6% |
Q2 2021 | $16,997,000 | -16.4% | 653,231 | +1.7% | 0.02% | -18.2% |
Q1 2021 | $20,327,000 | -35.6% | 642,032 | -5.6% | 0.02% | -37.1% |
Q4 2020 | $31,559,000 | +37.2% | 680,151 | -2.6% | 0.04% | +25.0% |
Q3 2020 | $22,995,000 | +20.9% | 698,510 | +0.8% | 0.03% | +16.7% |
Q2 2020 | $19,017,000 | +40.8% | 692,794 | +53.6% | 0.02% | +20.0% |
Q1 2020 | $13,505,000 | +16.8% | 451,141 | +8.0% | 0.02% | +42.9% |
Q4 2019 | $11,563,000 | +78.9% | 417,739 | +17.6% | 0.01% | +75.0% |
Q3 2019 | $6,464,000 | -19.5% | 355,138 | +8.5% | 0.01% | -20.0% |
Q2 2019 | $8,027,000 | +785.0% | 327,368 | +243.2% | 0.01% | +900.0% |
Q1 2019 | $907,000 | +27.2% | 95,400 | +18.4% | 0.00% | 0.0% |
Q4 2018 | $713,000 | -30.6% | 80,600 | -11.8% | 0.00% | 0.0% |
Q3 2018 | $1,028,000 | -12.1% | 91,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,170,000 | -11.9% | 91,400 | +16.3% | 0.00% | -50.0% |
Q1 2018 | $1,328,000 | +225.5% | 78,600 | +54.1% | 0.00% | – |
Q4 2017 | $408,000 | +3.3% | 51,000 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $395,000 | +5.3% | 51,000 | 0.0% | 0.00% | – |
Q2 2017 | $375,000 | – | 51,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |